Variantyx

About:

Variantyx is a molecular diagnostics company specializing in advanced genetic testing and diagnostics.

Twitter/X: variantyx

Top Investors: IBM Ventures, Bosch Ventures, Pitango VC, Kreos Capital, New Era Capital Partners

Description:

Based on clinical whole genome sequencing (WGS) and using a single patient sample, Variantyx's Genomic Unity® test identifies and reports all major variant types including small sequence changes, structural variants, mitochondrial variants and short tandem repeat expansions. This comprehensive test test eliminates the need for traditional step-wise, reiterative genetic testing.

Total Funding Amount:

$137M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Framingham, Massachusetts, United States

Founded Date:

2014-01-01

Founders:

Haim Neerman, Tomer Jackman

Number of Employees:

101-250

Last Funding Date:

2024-04-26

IPO Status:

Private

Industries: